Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve (a) audited financial statements (Consolidated & Standalone) for the financial year ending March 31, 2025. (b) audited financial results (Consolidated & Standalone) for the quarter and financial year ending March 31, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (c ) recommendation of dividend, if any for the Financial Year 2024-25.